These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 13915887)

  • 41. Effects of enzyme inhibitors on junction potentials in response to adrenergic nerve stimulation.
    Nakanishi H; Doteuchi N; Otani K; Tanaka H; Takeda H
    Jpn J Pharmacol; 1969 Dec; 19(4):535-42. PubMed ID: 4391522
    [No Abstract]   [Full Text] [Related]  

  • 42. Central effects of beta-phenylisopropylhydrazine and iproniazid.
    FURGIUELE AR; KINNARD WJ; BUCKLEY JP
    J Pharmacol Exp Ther; 1962 Sep; 137():356-60. PubMed ID: 13895937
    [No Abstract]   [Full Text] [Related]  

  • 43. [Derivatives of hydrazides and hydrazines inhibiting monoamine oxidase. Mechanisms cited to account for their pharmacological effects].
    LEVY J
    Actual Pharmacol (Paris); 1961; 14():125-73. PubMed ID: 14464772
    [No Abstract]   [Full Text] [Related]  

  • 44. Amine oxidases. XIX. Inhibition of monoamine oxidase by phenylcyclopropylamines and iproniazid.
    ZELLER EA; SARKAR S
    J Biol Chem; 1962 Jul; 237():2333-6. PubMed ID: 14010087
    [No Abstract]   [Full Text] [Related]  

  • 45. [INFLUENCE OF ISOCARBOXAZID (MARPLAN) AND 2 NEW MAO INHIBITORS ON CLONIC CONVULSIONS AND MORTALITY INDUCED BY METRAZOLE].
    SANSONE M; DELL OMODARME G
    Arch Int Pharmacodyn Ther; 1963 Aug; 144():392-8. PubMed ID: 14060861
    [No Abstract]   [Full Text] [Related]  

  • 46. [The influence of iproniazid and beta-phenylisopropylhydrazine (JB516) on the narcotic effect and decomposition of hexobarbital and thiopental].
    ARRIGONI-MARTELLI E; KRAMER M
    Med Exp Int J Exp Med; 1959; 1():45-51. PubMed ID: 13794503
    [No Abstract]   [Full Text] [Related]  

  • 47. ON THE GANGLIONIC ACTIONS OF CERTAIN ANTI-DEPRESSANT DRUGS.
    URQUIAGA X; VILLARREAL J; ALONSO-DEFLORIDA F; PARDO EG
    Arch Int Pharmacodyn Ther; 1963 Nov; 146():126-33. PubMed ID: 14077702
    [No Abstract]   [Full Text] [Related]  

  • 48. In vivo monoamine oxidase inhibition measured by potentiation of tryptamine convulsions in rats.
    TEDESCHI DH; TEDESCHI RE; FELLOWS EJ
    Proc Soc Exp Biol Med; 1960 Apr; 103():680-2. PubMed ID: 13837257
    [No Abstract]   [Full Text] [Related]  

  • 49. [Experimental animal research on the mechanism of the narcosis-shortening action of monoamine oxidase inhibitors].
    WESTERMANN E; STOCK K
    Chemotherapia (Basel); 1962; 4():329-39. PubMed ID: 14006333
    [No Abstract]   [Full Text] [Related]  

  • 50. Monoamine oxidase inhibiting properties of SU-11,739 in the rat. Comparison with pargyline, tranylcypromine and iproniazid.
    Maître L
    J Pharmacol Exp Ther; 1967 Jul; 157(1):81-8. PubMed ID: 6029494
    [No Abstract]   [Full Text] [Related]  

  • 51. [Action of reserpine and monoamine oxidase inhibitors on anaphylactic shock in mice].
    HALPERN BN; NEVEU T; BRANELLEC A; DRUDI-BARACCO C
    C R Seances Soc Biol Fil; 1962; 156():1739-43. PubMed ID: 13952223
    [No Abstract]   [Full Text] [Related]  

  • 52. Monoamine oxidase inhibitor reversal of parathion extension of hexobarbital action.
    Proctor CD
    Arch Int Pharmacodyn Ther; 1965 Apr; 154(2):468-73. PubMed ID: 4378733
    [No Abstract]   [Full Text] [Related]  

  • 53. [Conditions of the sensitization of rodents by hydrazides to audiogenic convulsive attack. Study of protective substances].
    BUCHEL L; DEBAY A; LEVY J; TANGUY O
    Therapie; 1961; 16():729-42. PubMed ID: 13874250
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical observations on iproniazid in idiots with epilepsy.
    REBHUN J
    Calif Med; 1960 Mar; 92(3):207-9. PubMed ID: 14436745
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Preliminary tests of the action of an MAO inhibitor (Iproniazid) on iris motility].
    Balacco-Gabrieli C
    Boll Soc Ital Biol Sper; 1971 Jan; 47(2):36-8. PubMed ID: 5088816
    [No Abstract]   [Full Text] [Related]  

  • 56. [Behavioral modifications observed following repeated administrations of monoamine oxidase inhibitors].
    Goldwurm GF; Torrigiani G
    Riv Neurobiol; 1964; 10(4):Suppl:1099-106. PubMed ID: 5827089
    [No Abstract]   [Full Text] [Related]  

  • 57. Correlation between monoamine oxidase inhibitors and anticonvulsants.
    Dwivedi C; Misra RS; Chaudhari A; Parmar SS
    J Natl Med Assoc; 1980 Oct; 72(10):953-5. PubMed ID: 7420438
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [New hydrazine derivatives with MAO-inhibiting action].
    DELL'OMODARME G; SANSONE M
    Arch Ital Sci Farmacol; 1961 Oct; 11():334-6. PubMed ID: 13885166
    [No Abstract]   [Full Text] [Related]  

  • 59. Neurologic, neuropathologic, and neurochemical effects of prolonged administration of phenylisopropylhydrazine (JB 516), phenylisobutylhydrazine (JB 835), and other monoamine oxidase inhibitors.
    MALING HM; HIGHMAN B; SPECTOR S
    J Pharmacol Exp Ther; 1962 Sep; 137():334-43. PubMed ID: 14468916
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of anticonvulsants on brain serotonin.
    Chase TN; Katz RI; Kopin IJ
    Trans Am Neurol Assoc; 1969; 94():236-8. PubMed ID: 5374444
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.